Program Leader of NeuroOncology and Chief of Neurosurgery
Moffitt Cancer Center
Tampa, FL, US
Michael A. Vogelbaum, MD, PhD, is Program Leader of NeuroOncology and Chief of Neurosurgery at Moffitt Cancer Center. He is also Professor of Oncological Sciences at the University of South Florida. Dr. Vogelbaum has an externally funded basic science and translational research program which currently focuses on immunobiology of brain tumors, Phase 0/Window of Opportunity clinical trials, and trials that involve active delivery of therapeutic agents to the brain. He also has invented and commercialized new technology for therapeutic delivery to the brain. Dr. Vogelbaum is a co-founder of the Response Assessment in NeuroOncology (RANO) group, Chair of the Neurosurgery Committee for NRG Oncology, and he has been a Vice President of the Society for NeuroOncology (SNO).
Disclosure(s): Biodexa: Advisor (Ongoing); DeNovo: Grant/Research Support (Ongoing); Infuseon Therapeutics: Grant/Research Support (Terminated, December 1, 2023); Olympus: Speaker/Honoraria (Ongoing); Oncosynergy: Grant/Research Support (Terminated, December 1, 2023); Servier: Advisor (Ongoing)
WHO II Meningioma Total Rection: Watch and Wait
Saturday, May 4, 2024
4:04 PM – 4:14 PM CT